Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
published in: The New England Journal of Medicine
date of publication: 2020-10-01
main subject: non-small-cell lung carcinoma
Cites articles
There is nothing here
Article - wd:Q100392003